MICHAEL ROBERTS

Lobbied in support of increased funding for the NIH, NIDDK, NCI and federal research funding for DoD and the VA.

Lobbied in support of HR 1017/S.479, the Removing Barriers to Colorectal Cancer Screening Act. Also advocated for changes to the MACRA law to provide CMS more flexibility when implementing MIPS in both the cost and performance categories.

Lobbied in support of HR 2077, the Restoring Patient's Voice Act

Lobbied in support of HR 1017/S.479, the Removing Barriers to Colorectal Cancer Screening Act. Also advocated for changes to the MACRA law to provide CMS more flexibility when implementing MIPS in both the cost and performance categories.

Lobbied in support of increased funding for the NIH, NIDDK, NCI and federal research funding for DoD and the VA.

Lobbied in support of retaining the essential health benefits package in the ACA along with other patient protections.

Lobbied in support of HR 1071, the Removing Barriers to CRC Screening Act, that would waive the cost sharing for a screening colonoscopy under Medicare regardless of the outcome.

Lobbied in support of increased research funding for NIH, NCI, NIDDK, DoD and VA medical research programs.

Lobbied in support of increased funding for the NIH, NIDDK, NCI and federal research funding for DoD and the VA.

Lobbied in support of HR 1017/S.479, the Removing Barriers to Colorectal Cancer Screening Act. Also advocated for changes to the MACRA law to provide CMS more flexibility when implementing MIPS in both the cost and performance categories.

Lobbied in support of retaining the essential health benefits package in the ACA along with other patient protections.

Lobbied in support of increased research funding for NIH, NCI, NIDDK, DoD and VA medical research programs.

Lobbied in support of HR 1071, the Removing Barriers to CRC Screening Act, that would waive the cost sharing for a screening colonoscopy under Medicare regardless of the outcome.

Lobbied in support of retaining the essential health benefits package in the ACA along with other patient protections.

Lobbied in support of increased research funding for NIH, NCI, NIDDK, DoD and VA medical research programs.

Lobbied in support of HR 1071, the Removing Barriers to CRC Screening Act, that would waive the cost sharing for a screening colonoscopy under Medicare regardless of the outcome.

Lobbied in support of funding for digestive disease research at NIH, VA and DoD.

Lobbied in support of H.R. 1220/S. 624, the Removing Barriers to Colorectal Cancer Screening Act. Also lobbied in favor of specialists being able to qualify as alternative payment models under MACRA.

Lobbied in support of the 21st Century Cures Act

Lobbied in support of funding increases for the NIH, NIDDK, VA Research Programs and DoD Research Programs.

Lobbied in support of the Electronic Health Record Improvement Act, legislation that would exempt patient encounters performed in an ASC from being counted toward a physician's meaningful use requirement. Lobbied in support of the 21st Century Cures Act.

Lobbied in support of H.R. 1220/S. 624, the Removing Barriers to Colorectal Cancer Screening Act, legislation that would waive the coinsurance for a screening colonoscopy regardless of the outcome of the screening. Lobbied in support of specialists being able to qualify as alternative payment models under MACRA.

Lobbied in support of H.R. 1220/S. 624, the Removing Barriers to Colorectal Cancer Screening Act. Also lobbied in favor of specialists being able to qualify as alternative payment models under MACRA.

Lobbied in support of funding for digestive disease research at NIH, VA and DoD.

Lobbied in support of H.R. 1220/S. 624, the Removing Barriers to Colorectal Cancer Screening Act, legislation that would waive the coinsurance for a screening colonoscopy regardless of the outcome of the screening. Lobbied in support of specialists being able to qualify as alternative payment models under MACRA.

Lobbied in support of funding increases for the NIH, NIDDK, VA Research Programs and DoD Research Programs.

Lobbied in support of S. 1347, Electronic Health Record Improvement Act, legislation that would exempt patient encounters performed in an ASC from being counted toward a physician's meaningful use requirement.

Lobbied in support of HR 1220/S 624, Removing Barriers to Colorectal Cancer Screening Act, legislation that would waive the coinsurance for Medicare screening colonoscopy regardless of the outcome of the screening. Lobbied in support of repealing the Sustainable Growth Rate used to calculate physician payments under Medicare.

Lobbied in support of the 21st Century Cures Act.

Lobbied in support of increased funding for NIH and NIDDK.

Lobbied in support of H.R. 1220/S. 624, the Removing Barriers to Colorectal Cancer Screening Act, legislation that would waive the coinsurance for a screening colonoscopy regardless of the outcome of the screening.

Lobbied in support of funding increases for the NIH, NIDDK, VA Research Programs and DoD Research Programs.

Lobbied in support of S. 1347, Electronic Health Record Improvement Act, legislation that would exempt patient encounters performed in an ASC from being counted toward a physician's meaningful use requirement.

Lobbied in support of repealing the sustainable growth rate formula used to calculate Medicare physician payment rates.

Lobbied in support of increased research funding for NIH, NIDDK, VA and DoD Cancer Research programs.

Lobbied in support of 21st Century Cures Act

Lobbied in support of the 21st Century Cures Act.

Lobbied in support of increased funding for NIH and NIDDK.

Lobbied in support of repeal the sustainable growth rate formula used to calculate Medicare physician payment rates.

Lobbied in support of 21st Century Cures Act and improvement in HIT interoperability.

Lobbied in support of the Removing Barriers to CRC Screening Act to waive the cost sharing for a screening colonoscopy regardless of the outcome. Also lobbied in support of more transparency at CMS when changing values of physician payments.

Lobbied in support of increased research funding for NIH, NCI, NIDDK, VA and DoD medical research programs.

Lobbied in support of the Removing Barriers to Screening Act, legislation to waive the screening colonoscopy coinsurance when the screening turns therapeutic. Also lobbied in support of a more transparent process at CMS for announcing changes in physician values.

Lobbied in support of increased funding for digestive disease research at NIH, NIDDK, VA and DoD.

Lobbied in support of increased funding for biomedical research at the NIH, VA and DoD.

Lobbied for support of the Eliminating Barriers to Colorectal Cancer Screening Act, legislation that would waive the coinsurance for Medicare beneficiaries whose screening colonoscopy becomes therapeutic. Also lobbied in support of a more open and transparent process when CMS makes changes to physician payment values.

Lobbied in support of increased research funding for the NIH, VA and DoD Cancer Reserach programs.

Lobbied in support of a permanent fix to the SGR Medicare Physician Payment formula. Lobbied in support of more transparency at CMS when publishing changes in physician values. Lobbied in support of H.R. 1070, Removing Barriers to Colorectal Cancer Screening Act. Lobbied in support of repealing IPAB.

Lobbied in support of a permanent fix to the SGR and meaningful physician payment reform. Lobbied in support of H.R. 1070, the Removing Barriers to Colorectal Cancer Screenings Act. Lobbied in support of the repeal of the Independent Payment Advisory Board (IPAB). Lobbied to maintain the current in-office ancillary services exception under Medicare.

Lobbied in support of federal funding of biomedical research and funding for the National Institutes of Health (NIH) and the Veterans Administration's research program.

Lobbied in support of federal funding of biomedical research and funding for the National Institutes of Health (NIH) and the Veterans Administration's research program.

Lobbied in support of a permanent fix to the SGR and meaningful physician payment reform. Lobbied in support of H.R. 1070, the Removing Barriers to Colorectal Cancer Screening act. Lobbied in support of repeal of the Independent Payment Advisory Board (IPAB). Lobbied to maintain the current in-office ancillary services exception under Medicare.

Lobbied in support of increased federal funding of biomedical research through the VA, NIH, NIDDK and DoD.

Lobbied in support of H.R. 5, the HEALTH Act, and other measures to reform medical liability. Also, advocated for legislation to repeal the Independent Payment Advisory Board (IPAB).

Advocated for a new Medicare physician payment system and a repeal of the SGR formula used to calculate Medicare payments. Also advocated in support of the Eliminating Barriers to Colorectal Cancer Screening which would waive the co-insurance for Medicare beneficiaries who undergo a screening colonoscopy that turns therapeutic.

Lobbied in support of federal funding of biomedical research and funding for the National Institutes of Health (NIH).

Lobbied in support of H.R. 1070, the Removing Barriers to Colorectal Cancer Screening Act. Lobbied in support of Medicare physician payment reform. Lobbied in support of repeal the Independent Payment Advisory Board (IPAB).

Lobbied for a permanent fix to the Medicare physician payment system and prevent the scheduled 26.5 percent cut from being implemeted. Lobbied to include registry recognition language in a year end SGR fix bill. Lobbied in support of HR 4120, Removing Barriers to Colorectal Cancer Screening Act.

Lobbied to prevent the automatic spending cuts to the National Institutes of Health (NIH) and urged funding of $32 billion for NIH for fiscal year 2013.

Lobbied in support of H.R. 733, the Pancreatic Cancer Research and Education Act. Lobbied in support of medical research funding for the NIH, VA and DoD.

Lobbied in support of H.R. 4120, Removing Barriers to Colorectal Cancer Screening Act. Lobbied to prevent a 27 percent cut to Medicare physician payments. Lobbied to delay the implementation of the value based payment modifier under Medicare.

Lobbied in support of increased funding for disgestive disease research at the NIH, NIDDK, VA and DoD.

Lobbied in support of medical liability reform and in support of HR 5.

Advocated in support of H.R. 5, the HEALTH Act, that would provide federal medical liability reform. Advocated in support of PDUFA and advocated that Congress address the drug shortage in the user fee authorization bill.

Lobbied in support of H.R. 4120, the Eliminate Barriers to Colorectal Cancer. Advocated for a repeal of the sustainable growth rate formula (SGR) that determines Medicare physician payments. Lobbied in support of H.R. 452, the Medicare Decisions Accountability Act.

Advocated for a technical correction to the Medicare screening colonoscopy coinsurance waiver to ensure that the coinsurance is waived when the screening becomes therapeutic. Advocated for a repeal of the SGR formula used to determine Medicare physician payment updates. Also advocated for the repeal of the Independent Payment Advisory Board and in support of the ASC Access and Quality Act.

Advocated for increased medical research funding for the NIH, NIDDK and the VA to support digestive disease research.

Advocated for a technical correction to the Medicare colorectal cancer coinsurance waiver to ensure that the coinsurance is waived for a screening colonoscopy that becomes therapeutic. Advocated for repeal of the sustainable growth rate formula (SGR) and that Congress prevent a 30 percent reduction in physician reimbursement for Medicare services. Also advocated for the repeal of the Independent Payment Advisory Board (IPAB) and in support of the ASC Access and Quality Act.

Advocated in support of H.R. 5, the HEALTH Act, that would provide federal medical liability reform.

Lobbied for increased federal funding for medical research for the NIH, NIDDK, VA and DOD. Also lobbied for the implementation of the recommendations of the National Commission on Digestive Diseases.

Lobbied for a permanent fix to the Medicare physician payment formula. Lobbied for a waiver of the copayment for colorectal cancer screenings under Medicare when the colonoscopy becomes therapeutic. Lobbied in favor of repeal of the Independent Payment Advisory Board (IPAB).

Lobbied in support of H.R. 5, the HEALTH Act, that would reform medical liability. Also lobbied in support of the Colorectal Cancer Early Detection, Prevention and Treatment Act.

Lobbied for a permanent fix to the Medicare physician payment formula; advocated for the repeal of the Independent Payment Advisory Board; advocated for the waiver of the copayment for Medicare colorectal cancer screening for therapeutic colonoscopy.

Advocated for increased funding for digestive disease research at hte NIH, NIDDK, and the VA and lobbied against cuts to research in H.R. 1.

Lobbied for increased research funding for digestive disease research at NIH and the VA. Also lobbied for support and passage of H.Res. 1444 which commemorates the 60th anniversary of the NIDDK.

Lobbied for a permanent fix to the Medicare physician payment formula and to prevent a 25 percent cut in physician reimbursement. Also lobbied for a technical correction to the Medicare colorectal cancer screening waiver of copayment for a screening colonoscopy that becomes therapeutic.

Lobbied for increased funding for federal funding of digestive disease research at the NIH, NIDDK and VA. Also advocated in support of H.Res. 1444 which commemorates the 60th anniversary of the NIDDK.

Lobbied for a permanent fix to the Medicare physician payment formula and to prevent a 23 percent cut in physician reimbursement scheduled for Dec. 1, 2010. Also lobbied for the elimination of the Independent Payment Advisory Board under PPACA which would make funding recommendations on Medicare. Also lobbied for a technical correction to the screening provisions under PPACA for Medicare beneficiaries that the co-payment be waived for a screening colonoscopy that becomes therapeutic.

Advocated for health care reform and issues concerning expanding access to colorectal cancer screenings, comparative effectiveness research, access to specialty care and opposition to the Independent Payment Advisory Board.

Advocated for increased funding for digestive disease research at the NIH, NIDDK, and the VA. Also advocated for the implementation of the recommendations of the National Commission on Digestive Diseases. Also lobbied in support of a resolution, H.Res. 1444, to commemorate the 60th anniversary of NIDDK.

Advocated for health care reform and issues concerning expanding access to colorectal cancer screenings, comparative effectiveness research, access to specialty care and opposition to an Independent Payment Advisory Board. Also advocated in support of increased funding for the CDC's Colorectal Cancer Screening Program.

Advocated for increased funding for digestive disease research at the NIH, NIDDK and the VA. Also advocated for implementation of the recommendations of the National Commission on Digestive Diseases.

Advocated for health care reform and issues concerning expanding access to colorectal cancer screening, comparative effectiveness research, health information technology, access to specialty care and graduate medical education.

Lobbied for a permanent fix to the Medicare Physician Payment formula and to prevent a 21% cut from being implemented in January 2010. Also lobbied in support of HR 3961, the Medicare Physician Payment Reform Act. Also lobbied in support of a technical correction to the Medicare colorectal cancer screening deductible to ensure the deductible is waived regardless if a polyp or lesion is found. Also lobbied for a one-year delay in the elimination of consultation codes by CMS.

Advocated for health care reform and issues concerning comparative effectiveness research, health information technology, access to specialty care, and graduate medical education. Also advocated for increased access and coverage of colorectal cancer screenings for the uninsured and underinsured.

Lobbied for a permanent fix to the Medicare physician payment formula and to prevent a 21% cut from being implemented in January 2010. Also lobbied for a technical correction to the Medicare colorectal cancer screening deductible waiver to allow the waiver regardless if a polyp or lesion is found. Also lobbied to secure access to medical specialists.

Advocated for health care reform and issues concerning comparative effectiveness research, health information technology, access to specialty care, and graduate medical education. Also advocated for increased access to colorectal cancer screenings for the uninsured and underinsured.

Lobbied for a permanent fix to the Medicare physician payment formula and to prevent a 21% cut from being implemented in January 2010. Also lobbied for a technical correction to the Medicare colorectal cancer screening deductible waiver to allow the waiver regardless if a polyp or lesion is found. Also lobbied to secure access to medical specialists.

Advocate for reforming the current Medicare physician payment system and preventing a 20 percent cut in physician payments. Also lobbied for fair reimbursement for gastroenterologists. Also, lobbied for a technical correction to the current Medicare colorectal cancer deductible waiver for beneficiaries and that it be changed to waive the deductible regardless if a polyp or lesion is found.

Lobbied in support of H.R. 1189, the Colorectal Cancer Early Detection, Prevention and Treatment Act, to provide grants to states to develop screening programs for the at-risk, uninsured and underinsured populations. Also, lobbied in support of S. 717, the 21st Century ALERT Act, which would also create a colorectal cancer screening program and increase research programs for high mortality cancers such as esophageal, liver and stomach.

Advocated for increased federal funding for digestive diesease research and increased funding for the NIH and NIDDK. Advocate for language in the Labor-HHS Education Appropriations bill on funding recommendations in the final report of the National Commission on Digestive Diseases. Also lobbied in support of an Institute of Medicine study to examine the plight of the MD/PhD investigator and issues involved with recruitment and retention of physician-scientists.

Lobbied in support of H.R. 1738, the Colorectal Cancer Early Detection, Prevention and Treatment Act, to provide grants to states to develop screening programs for the at-risk, uninsured and underinsured population. Also lobbied in support of access to specialty medicine in the context of health care reform.

Advocate for reforming the Medicare physician payment system and preventing a 10.6 percent cut in physician payments. Lobbied in support of H.R. 6331, the Medicare Improvement for Patients and Providers Act (H.R. 6331).

Lobbied in support of H.R. 1738, the Colorectal Cancer Early Detection, Prevention and Treatment Act, to provide grants to states to develop screening programs for the at-risk, uninsured and underinsured population.

Advocate increased federal funding for digestive disease research and increased funding for NIH, NIDDK, and VA research programs. Advocate for language in the Labor-HHS-Education Appropriations bill on funding recommendations in the final report of the National Commission on Digestive Diseases. Also lobbied in support of an Insitute of Medicine study to examine the plight of the MD/PhD investigator and issues involved with recruitment and retention of physician-scientists.

Advocate for reforming the Medicare physician payment formula and preventing a 10.6 percent cut in physician payments. Lobbied in support of clarrifying the current Medicare deductible waiver for colorectal cancer screenings to include removal of polyps and/or lesions.

Advocate increased federal funding for digestive disease research and increased funding for NIH, NIDDK, and VA Research programs. Advocate for language in the Labor-HHS-Education Appropriations bill on funding recommendations in the final report of the National Commission on Digestive Diseases.

Advocate increased federal funding for digestive disease research and increased funding for NIH, NIDDK and VA Research program. Meet to discuss details of the final report on the National Commission on Digestive Diseases.

Lobbied in support of S. 1519 and H.R. 2749, the Medicare Voluntary Physician Reporting Act, that would revamp the current Physician Quality Reporting Program (PQRI) and require Congress to study the pilot before moving to a permanent program.

Lobbied in support of H.R. 1738, the Colorectal Cancer Early Detection, Prevention and Treatment Act, to provide grants to states to develop screening programs for the at-risk, uninsured and underinsured populations.

Lobbied in support of S. 1519 and H.R. 2749, the Medicare Voluntary Physician Reporting Act, that would revamp the current Physician Quality Reporting Program (PQRI) and require Congress to study the pilot before moving toward a more permanent program. Advocate for reforming the Medicare Physician Payment formula and preventing physician reimbursement cuts. Lobbied in support of the CHAMP Act. Lobbied in support of clarifying the current Medicare deductible waiver for colorectal cancer screenings to include removal of polyps and/or lesions.

Lobbied to revamp the current Medicare physician payment formula and prevent physician payment cuts. Lobbied in support of H.R.2749/S.1519, the Voluntary Medicare Quality Reporting Act. Lobbied against proposed cuts to gastroenterology in ambulatory surgery centers. Lobbied to correct the waiver of deductible for colorectal cancer screenings under Medicare.

Lobbied in support of H.R. 1738, the Colorectal Cancer Prevention and Treatment Act

Lobbied for increased research funding for digestive disease research at NIH, NIDDK and NCI.

Medicare physician payment reform; medical liability reform; health information technology; increased access to colorectal cancer screening.

Medicare physician payment reform; medical liability reform; health information technology; increased access to colorectal cancer screening.

Medicare physician payment reform; medical liability reform; health information technology; increased access to colorectal cancer screening.

Medical liability reform; Medicare physician payment reform; health information technology; research funding for disgestive disease research; increased access to colorectal cancer screenings.

Medical liability reform; Medicare physician payment reform; health information technology; research funding for disgestive disease research; increased access to colorectal cancer screenings.

Medical liability reform; Medicare physician payment reform; health information technology; research funding for disgestive disease research; increased access to colorectal cancer screenings.

Advocated for the implementation of the National Commission on Digestive Diseases Advocated for increased funding for the NIH, NIDDK

Advocated for medical liablity reform

Advocated for changes to the Medicare Physician Payment formula